1,108 results on '"Egeberg, Alexander"'
Search Results
2. Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib
3. Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of Exposure
4. Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60
5. Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
6. Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials
7. Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
8. A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
9. Adult patients with alopecia areata report a significantly better medication adherence compared to those with atopic dermatitis: Results from a large cross-sectional cohort study
10. Effects of oral roflumilast therapy on body weight and cardiometabolic parameters in patients with psoriasis – results from a randomized controlled trial (PSORRO)
11. Characteristics and drivers of fatigue in patients with psoriasis and psoriatic arthritis: A cross sectional study
12. Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa
13. No associations between type 1 diabetes and atopic dermatitis, allergic rhinitis, or asthma in childhood: a nationwide Danish case-cohort study
14. Nail psoriasis dynamics during biologic treatment and withdrawal in patients with psoriasis who may be at high risk of developing psoriatic arthritis: a post hoc analysis of the VOYAGE 2 randomized trial
15. Development and internal validation of a diagnostic prediction model for psoriasis severity
16. A fragment of type VI collagen alpha-6 chain is elevated in serum from patients with atopic dermatitis, psoriasis, hidradenitis suppurativa, systemic lupus erythematosus and melanoma
17. Adverse events from topical corticosteroid use in chronic hand eczema — Findings from the Danish Skin Cohort
18. Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)
19. Use of methotrexate and risk of skin cancer: a nationwide case–control study
20. Drug Survival of Adalimumab, Secukinumab, and Ustekinumab in Psoriasis as Determined by Either Dose Escalation or Drug Discontinuation during the First 3 Years of Treatment – a Nationwide Cohort Study
21. Abstract 17301: C-Reactive Protein and Long-Term Risk of Death in Patients With Myocardial Infarction
22. Reduced Skin Microbiome Diversity in Infancy Is Associated with Increased Risk of Atopic Dermatitis in High-Risk Children
23. Combination Therapy with Apremilast and Biologics for Psoriasis: A Systematic Review
24. Erenumab for Treatment of Persistent Erythema and Flushing in Rosacea
25. Elevated plasma levels of calcitonin gene‐related peptide in individuals with rosacea: A cross‐sectional case–control study
26. Psoriasis and adverse pregnancy outcomes: A nationwide case-control study in 491,274 women in Denmark
27. Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries
28. Incidence and geographic differences in keratinocyte carcinoma and Bowen's disease in office‐based dermatological practice between 2013 and 2022: A nationwide Danish registry‐based study.
29. Increased loss‐of‐function filaggrin gene mutation prevalence in atopic dermatitis patients across northern latitudes indicates genetic fitness: A systematic review and meta‐analysis.
30. Symptom burden of patients with moderate-to-severe atopic dermatitis
31. Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis: A Cross-sectional Global Healthcare Study on Psoriasis
32. Fatigue is associated with disease severity in adult patients with hidradenitis suppurativa
33. The burden of head-and-neck dermatitis in adults with atopic dermatitis and its association with asthma, rhinitis, and disease severity
34. Drug Survival of Biologics in Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis
35. Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective
36. Characteristics of Patients With Psoriasis Treated With Various Biologics – A Danish Cohort Study
37. 534 - Incidence of venous thromboembolic events and atherosclerotic cardiovascular disease risk factors in adolescents and adults with atopic dermatitis in Denmark: a population-based cohort study
38. Risk Factors that Impact Treatment with Oral Janus Kinase Inhibitors Among Adult Patients with Atopic Dermatitis: A Nationwide Registry Study
39. The agreement between consumer-driven self-assessment of psoriasis severity and physician-assessed severity based on patient-taken photographs is weak: cross-sectional study
40. Estimating the burden of skin diseases using patient‐reported daily time trade‐off as a measure of disease impact and unmet needs
41. Rosacea and Neurological Comorbidities
42. Rosacea and Gastrointestinal Comorbidities
43. Rosacea and Cardiovascular Comorbidities
44. Rosacea and Cancer
45. Bidirectional association between atopic dermatitis, conjunctivitis, and other ocular surface diseases: A systematic review and meta-analysis
46. Rhinitis prevalence and association with atopic dermatitis: A systematic review and meta-analysis
47. Infusion of Pituitary Adenylate Cyclase–Activating Polypeptide-38 in Patients with Rosacea Induces Flushing and Facial Edema that Can Be Attenuated by Sumatriptan
48. Awareness and Expectations Surrounding Family Planning and Pregnancy Among Danish Patients with Chronic Inflammatory Disease of the Skin or Joints: Results from an Online Survey
49. Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program
50. Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.